Symbols / IRIX Stock $1.05 -1.87% IRIDEX Corporation

Healthcare • Medical Devices • United States • NCM
IRIX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Stock Fundamentals
Scroll to Statements
Market Cap 18.17M Enterprise Value 22.68M Income -4.44M Sales 52.67M Book/sh -0.06 Cash/sh 0.35
Dividend Yield — Payout 0.00% Employees — IPO — P/E — Forward P/E inf
PEG 0.94 P/S 0.34 P/B -16.94 P/C — EV/EBITDA -9.77 EV/Sales 0.43
Quick Ratio 1.18 Current Ratio 1.91 Debt/Eq 92.08 LT Debt/Eq — EPS (ttm) -0.26 EPS next Y 0.00
EPS Growth — Revenue Growth 16.00% Earnings 2026-05-12 ROA -5.51% ROE -126.43% ROIC —
Gross Margin 36.50% Oper. Margin -0.10% Profit Margin -8.42% Shs Outstand 17.31M Shs Float 10.95M Short Float 0.24%
Short Ratio 0.58 Short Interest — 52W High 1.65 52W Low 0.87 Beta 0.76 Avg Volume 267.31K
Volume 36.20K Target Price $2.75 Recom None Prev Close $1.07 Price $1.05 Change -1.87%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.75
Mean price target
2. Current target
$1.05
Latest analyst target
3. DCF / Fair value
$1.59
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.05
Low
$2.75
High
$2.75
Mean
$2.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-05-15 main Stifel Hold → Hold $2
2022-08-26 down Stifel Buy → Hold $3
2021-05-12 main Roth Capital — → Buy $11
2021-03-03 main Roth Capital — → Buy $9
2021-01-13 main Roth Capital — → Buy $6
2020-05-12 main Stifel — → Buy $4
2019-01-04 main Stifel Buy → Buy $7
2018-10-26 init Stifel — → Buy $9
2016-12-21 init Roth Capital — → Buy $20
2016-01-26 init Singular Research — → Buy $12
News
RSS: Latest IRIX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 DIZON ROMEO R Chief Financial Officer — 1,110 $1.26 $1,399
2026-02-17 DIZON ROMEO R Chief Financial Officer — 2,200 $1.31 $2,942
2026-02-12 DIZON ROMEO R Chief Financial Officer — 1,500 $1.43 $2,145
2026-02-10 DIZON ROMEO R Chief Financial Officer — 1,000 $1.46 $1,460
2026-02-03 DIZON ROMEO R Chief Financial Officer — 2,500 $1.38 $3,450
2026-01-29 DIZON ROMEO R Chief Financial Officer — 1,101 $1.44 $1,588
2026-01-28 DIZON ROMEO R Chief Financial Officer — 1,300 $1.46 $1,898
2026-01-27 DIZON ROMEO R Chief Financial Officer — 3,385 $1.48 $5,009
2026-01-26 DIZON ROMEO R Chief Financial Officer — 1,243 $1.52 $1,889
2026-01-23 DIZON ROMEO R Chief Financial Officer — 5,221 $1.48 $7,716
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
52.67
+8.23%
48.67
-6.17%
51.87
-8.96%
56.97
Operating Revenue
52.67
+8.23%
48.67
-6.17%
51.87
-8.96%
56.97
Cost Of Revenue
33.45
+14.68%
29.17
-2.98%
30.06
-4.88%
31.60
Reconciled Cost Of Revenue
33.45
+14.68%
29.17
-2.98%
30.06
-4.88%
31.60
Gross Profit
19.23
-1.41%
19.50
-10.57%
21.81
-14.04%
25.37
Operating Expense
21.80
-21.60%
27.80
-12.60%
31.81
-3.33%
32.91
Research And Development
3.67
-32.68%
5.45
-20.21%
6.83
-4.82%
7.17
Selling General And Administration
18.13
-18.90%
22.36
-10.53%
24.98
-2.91%
25.73
Selling And Marketing Expense
10.40
-17.35%
12.58
-22.53%
16.24
-10.68%
18.18
General And Administrative Expense
7.73
-20.89%
9.78
+11.75%
8.75
+15.76%
7.56
Other Gand A
7.73
-20.89%
9.78
+11.75%
8.75
+15.76%
7.56
Total Expenses
55.25
-3.03%
56.97
-7.93%
61.88
-4.09%
64.51
Operating Income
-2.57
+69.03%
-8.30
+17.04%
-10.01
-32.68%
-7.54
Total Operating Income As Reported
-2.57
+69.03%
-8.30
+17.04%
-10.01
-32.68%
-7.54
EBITDA
-1.02
+85.11%
-6.88
+13.76%
-7.97
-29.51%
-6.16
Normalized EBITDA
-1.02
+85.11%
-6.88
+13.76%
-7.97
-29.51%
-6.16
Reconciled Depreciation
1.55
+8.64%
1.42
-29.92%
2.03
+46.82%
1.38
EBIT
-2.57
+69.03%
-8.30
+17.04%
-10.01
-32.68%
-7.54
Net Income
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Pretax Income
-4.38
+50.46%
-8.84
+6.73%
-9.48
-26.70%
-7.48
Other Income Expense
-1.81
-235.00%
-0.54
-202.47%
0.53
+778.33%
0.06
Other Non Operating Income Expenses
-1.81
-235.00%
-0.54
-202.47%
0.53
+778.33%
0.06
Tax Provision
0.06
-16.18%
0.07
-24.44%
0.09
+38.46%
0.07
Tax Rate For Calcs
0.00
+90.48%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Net Income From Continuing Operation Net Minority Interest
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Net Income From Continuing And Discontinued Operation
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Net Income Continuous Operations
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Normalized Income
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Net Income Common Stockholders
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Diluted EPS
-0.26
+51.85%
-0.54
+8.47%
-0.59
-25.53%
-0.47
Basic EPS
-0.26
+51.85%
-0.54
+8.47%
-0.59
-25.53%
-0.47
Basic Average Shares
16.93
+3.01%
16.44
+1.93%
16.13
+1.19%
15.94
Diluted Average Shares
16.93
+3.01%
16.44
+1.93%
16.13
+1.19%
15.94
Diluted NI Availto Com Stockholders
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
29.15
+0.05%
29.14
-15.39%
34.44
-18.57%
42.29
Current Assets
25.25
+7.17%
23.56
-14.16%
27.45
-23.25%
35.77
Cash Cash Equivalents And Short Term Investments
6.03
+152.53%
2.39
-66.06%
7.03
-49.48%
13.92
Cash And Cash Equivalents
6.03
+152.53%
2.39
-66.06%
7.03
-49.48%
13.92
Receivables
9.54
+13.71%
8.39
-13.05%
9.65
-1.17%
9.77
Accounts Receivable
7.61
+27.93%
5.95
-11.54%
6.73
+7.99%
6.23
Gross Accounts Receivable
7.72
+24.40%
6.21
-9.65%
6.87
+3.84%
6.62
Allowance For Doubtful Accounts Receivable
-0.11
+56.76%
-0.26
-77.40%
-0.15
+62.56%
-0.39
Inventory
7.88
-27.18%
10.82
+9.20%
9.91
-6.62%
10.61
Raw Materials
4.15
-2.08%
4.24
-19.89%
5.29
-9.14%
5.82
Work In Process
0.00
0.00
-100.00%
0.16
-51.25%
0.32
Finished Goods
3.73
-43.34%
6.58
+47.49%
4.46
-0.13%
4.47
Prepaid Assets
—
—
—
—
Other Current Assets
1.80
-8.25%
1.96
+129.44%
0.86
-41.69%
1.47
Total Non Current Assets
3.90
-30.03%
5.57
-20.24%
6.99
+7.08%
6.52
Net PPE
0.83
-56.69%
1.91
-36.07%
2.98
+40.24%
2.13
Gross PPE
15.01
-5.54%
15.89
-4.98%
16.72
+6.61%
15.69
Accumulated Depreciation
-14.18
-1.43%
-13.98
-1.77%
-13.74
-1.33%
-13.56
Properties
0.00
0.00
0.00
0.00
Other Properties
12.52
-6.58%
13.40
-5.85%
14.23
+7.86%
13.19
Leases
2.49
+0.00%
2.49
+0.00%
2.49
+0.00%
2.49
Goodwill And Other Intangible Assets
1.95
-14.18%
2.27
-12.89%
2.61
-11.39%
2.94
Goodwill
0.96
+0.00%
0.96
+0.00%
0.96
+0.00%
0.96
Other Intangible Assets
0.98
-24.66%
1.31
-20.46%
1.64
-16.94%
1.98
Other Non Current Assets
1.12
-19.37%
1.39
-0.14%
1.40
-4.05%
1.46
Total Liabilities Net Minority Interest
24.23
-10.39%
27.04
+8.53%
24.91
-0.58%
25.06
Current Liabilities
13.21
-20.24%
16.56
+27.63%
12.97
+4.18%
12.45
Payables And Accrued Expenses
6.49
-24.26%
8.57
+21.90%
7.03
+25.80%
5.59
Payables
5.67
-27.32%
7.80
+56.77%
4.98
+23.05%
4.04
Accounts Payable
5.38
-22.91%
6.99
+55.26%
4.50
+16.61%
3.86
Other Payable
0.14
+140.35%
0.06
-61.74%
0.15
+40.57%
0.11
Current Accrued Expenses
0.82
+6.75%
0.77
-62.53%
2.06
+33.01%
1.54
Pensionand Other Post Retirement Benefit Plans Current
2.34
+39.95%
1.67
+3.27%
1.62
-33.86%
2.45
Total Tax Payable
0.03
-79.33%
0.15
+50.00%
0.10
+53.85%
0.07
Current Debt And Capital Lease Obligation
0.70
-75.28%
2.83
+184.22%
0.99
-4.05%
1.04
Current Debt
—
1.73
—
—
Other Current Borrowings
—
1.73
—
—
Current Capital Lease Obligation
0.70
-36.11%
1.09
+9.95%
0.99
-4.05%
1.04
Current Deferred Liabilities
3.68
+5.42%
3.49
+4.78%
3.33
-1.48%
3.38
Current Deferred Revenue
3.68
+5.42%
3.49
+4.78%
3.33
-1.48%
3.38
Total Non Current Liabilities Net Minority Interest
11.02
+5.17%
10.48
-12.24%
11.94
-5.28%
12.61
Long Term Debt And Capital Lease Obligation
3.83
+111.18%
1.81
+3.66%
1.75
+139.21%
0.73
Long Term Debt
3.73
+272.01%
1.00
—
—
Long Term Capital Lease Obligation
0.10
-87.92%
0.81
-53.68%
1.75
+139.21%
0.73
Long Term Provisions
—
—
—
—
Non Current Deferred Liabilities
6.80
-18.55%
8.35
-16.71%
10.03
-14.62%
11.74
Non Current Deferred Revenue
6.80
-18.55%
8.35
-16.71%
10.03
-14.62%
11.74
Other Non Current Liabilities
0.39
+23.25%
0.31
+91.46%
0.16
+530.77%
0.03
Stockholders Equity
4.92
+134.72%
2.10
-77.98%
9.52
-44.74%
17.23
Common Stock Equity
-1.08
-151.41%
2.10
-77.98%
9.52
-44.74%
17.23
Capital Stock
6.17
+3448.28%
0.17
+1.16%
0.17
+1.78%
0.17
Common Stock
0.17
+0.00%
0.17
+1.16%
0.17
+1.78%
0.17
Preferred Stock
6.00
0.00
0.00
0.00
Share Issued
17.31
+4.03%
16.64
+2.36%
16.25
+1.65%
15.99
Ordinary Shares Number
17.31
+4.03%
16.64
+2.36%
16.25
+1.65%
15.99
Additional Paid In Capital
91.21
+1.48%
89.88
+1.62%
88.44
+1.89%
86.80
Retained Earnings
-92.45
-5.04%
-88.01
-11.34%
-79.04
-13.38%
-69.72
Gains Losses Not Affecting Retained Earnings
-0.01
-127.45%
0.05
+198.08%
-0.05
-116.67%
-0.02
Other Equity Adjustments
-0.01
-127.45%
0.05
+198.08%
-0.05
-116.67%
-0.02
Total Equity Gross Minority Interest
4.92
+134.72%
2.10
-77.98%
9.52
-44.74%
17.23
Total Capitalization
8.66
+179.17%
3.10
-67.43%
9.52
-44.74%
17.23
Working Capital
12.04
+71.98%
7.00
-51.62%
14.48
-37.91%
23.31
Invested Capital
2.66
-45.05%
4.83
-49.22%
9.52
-44.74%
17.23
Total Debt
4.53
-2.39%
4.64
+69.08%
2.75
+55.23%
1.77
Net Debt
—
0.35
—
—
Capital Lease Obligations
0.80
-58.16%
1.91
-30.63%
2.75
+55.23%
1.77
Net Tangible Assets
2.97
+1808.62%
-0.17
-102.52%
6.92
-51.61%
14.29
Tangible Book Value
-3.03
-1639.66%
-0.17
-102.52%
6.92
-51.61%
14.29
Current Provisions
—
—
—
—
Duefrom Related Parties Current
1.93
-20.92%
2.44
-16.54%
2.93
-17.29%
3.54
Dueto Related Parties Current
0.12
-80.79%
0.61
+167.11%
0.23
+1420.00%
0.01
Non Current Accrued Expenses
—
—
0.14
+30.19%
0.11
Preferred Stock Equity
6.00
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-2.12
+70.97%
-7.29
-8.01%
-6.75
+29.14%
-9.52
Cash Flow From Continuing Operating Activities
-2.12
+70.97%
-7.29
-8.01%
-6.75
+29.14%
-9.52
Net Income From Continuing Operations
-4.44
+50.20%
-8.91
+6.90%
-9.57
-26.81%
-7.55
Depreciation Amortization Depletion
1.55
+8.64%
1.42
-29.92%
2.03
+46.82%
1.38
Depreciation
1.55
+8.64%
1.42
-29.92%
2.03
+46.82%
1.38
Depreciation And Amortization
1.55
+8.64%
1.42
-29.92%
2.03
+46.82%
1.38
Other Non Cash Items
0.23
-30.79%
0.33
—
—
Stock Based Compensation
0.78
-37.65%
1.24
-24.67%
1.65
+1.79%
1.62
Provisionand Write Offof Assets
—
—
0.00
-100.00%
0.19
Asset Impairment Charge
0.82
0.00
—
—
Operating Gains Losses
1.33
—
—
—
Gain Loss On Sale Of PPE
—
—
—
0.00
Change In Working Capital
—
—
—
—
Change In Receivables
-1.15
-191.35%
1.26
+251.96%
0.36
+251.05%
-0.24
Changes In Account Receivables
-1.66
-314.18%
0.78
+405.51%
-0.25
-229.59%
0.20
Change In Inventory
2.12
+332.38%
-0.91
-241.46%
0.64
+121.33%
-3.02
Change In Prepaid Assets
0.16
+114.62%
-1.11
-281.05%
0.61
+254.16%
-0.40
Change In Payables And Accrued Expense
-1.65
-217.56%
1.40
+196.19%
0.47
+364.25%
-0.18
Change In Accrued Expense
0.80
+154.50%
-1.47
-284.78%
-0.38
+41.65%
-0.65
Change In Payable
-2.45
-185.32%
2.87
+235.71%
0.85
+80.17%
0.47
Change In Account Payable
-1.95
-178.60%
2.49
+287.83%
0.64
-40.98%
1.09
Change In Other Working Capital
-1.56
+17.76%
-1.90
-10.45%
-1.72
-298.50%
0.87
Change In Other Current Assets
0.27
+13400.00%
0.00
+100.47%
-0.43
+63.97%
-1.19
Change In Other Current Liabilities
-0.57
-414.41%
-0.11
+86.02%
-0.79
+21.77%
-1.01
Investing Cash Flow
-0.14
-1000.00%
-0.01
+88.07%
-0.11
+61.89%
-0.29
Cash Flow From Continuing Investing Activities
-0.14
-1000.00%
-0.01
+88.07%
-0.11
+61.89%
-0.29
Net PPE Purchase And Sale
-0.14
-1000.00%
-0.01
+88.07%
-0.11
+61.89%
-0.29
Purchase Of PPE
-0.14
-1000.00%
-0.01
+88.07%
-0.11
+61.89%
-0.29
Sale Of PPE
—
—
—
—
Capital Expenditure
-0.14
-1000.00%
-0.01
+88.07%
-0.11
+61.89%
-0.29
Net Business Purchase And Sale
—
—
—
0.00
Purchase Of Business
—
—
—
0.00
Financing Cash Flow
5.96
+128.94%
2.60
+52200.00%
-0.01
+93.15%
-0.07
Cash Flow From Continuing Financing Activities
5.96
+128.94%
2.60
+52200.00%
-0.01
+93.15%
-0.07
Net Issuance Payments Of Debt
-3.96
-1716.97%
-0.22
0.00
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
-3.96
-1716.97%
-0.22
0.00
—
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-3.96
-1716.97%
-0.22
0.00
—
Net Long Term Debt Issuance
-3.96
-1716.97%
-0.22
0.00
—
Net Common Stock Issuance
4.00
+18.69%
3.37
0.00
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.00
-95.12%
0.08
+290.48%
0.02
Net Other Financing Charges
-0.07
+86.39%
-0.55
-533.33%
-0.09
+7.45%
-0.09
Changes In Cash
3.71
+178.97%
-4.69
+31.58%
-6.86
+30.56%
-9.88
Effect Of Exchange Rate Changes
-0.07
-241.30%
0.05
+258.62%
-0.03
+44.23%
-0.05
Beginning Cash Position
2.39
-66.06%
7.03
-49.48%
13.92
-41.63%
23.85
End Cash Position
6.03
+152.53%
2.39
-66.06%
7.03
-49.48%
13.92
Free Cash Flow
-2.26
+69.06%
-7.30
-6.48%
-6.85
+30.10%
-9.80
Income Tax Paid Supplemental Data
—
0.01
-71.70%
0.05
-27.40%
0.07
Common Stock Issuance
4.00
+18.69%
3.37
0.00
0.00
Issuance Of Capital Stock
10.00
+196.74%
3.37
0.00
0.00
Net Preferred Stock Issuance
6.00
0.00
—
—
Preferred Stock Issuance
6.00
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category